1. Robinson SJ, Kenyon AJ. History of alcohol, values and
legislation. In: Ethics in the Alcohol Industry. London: Palgrave
Macmillan; 2009. p. 8-22. doi: 10.1057/9780230250581_2.
2. World Health Organization (WHO). Global Status Report
on Alcohol and Health 2018. Geneva: WHO; 2018.
Available from: https://www.who.int/publications/i/
item/9789241565639.
3. World Health Organization (WHO). Epidemiology of Alcohol
use in the WHO South-East Asia Region. Geneva: WHO;
2018. Available from: https://www.who.int/publications/i/
item/9789290225348.
4. Meza V, Arnold J, Díaz LA, Ayala Valverde M, Idalsoaga F,
Ayares G, et al. Alcohol consumption: medical implications,
the liver and beyond. Alcohol Alcohol. 2022;57(3):283-91.
doi: 10.1093/alcalc/agac013.
5. Rehm J, Mathers C, Popova S, Thavorncharoensap M,
Teerawattananon Y, Patra J. Global burden of disease and
injury and economic cost attributable to alcohol use and
alcohol-use disorders. Lancet. 2009;373(9682):2223-33. doi:
10.1016/s0140-6736(09)60746-7.
6. Jyani G, Prinja S, Ambekar A, Bahuguna P, Kumar R. Health
impact and economic burden of alcohol consumption in
India. Int J Drug Policy. 2019;69:34-42. doi: 10.1016/j.
drugpo.2019.04.005.
7. Mutschler J, Grosshans M, Soyka M, Rösner S. Current findings
and mechanisms of action of disulfiram in the treatment of
alcohol dependence. Pharmacopsychiatry. 2016;49(4):137-
41. doi: 10.1055/s-0042-103592.
8. Kapri P, De Sousa A. Optimizing patient care in alcohol
dependence using disulfiram therapy. In: Handbook on
Optimizing Patient Care in Psychiatry. Routledge; 2022.
9. Sinclair JMA, Chambers SE, Shiles CJ, Baldwin DS. Safety
and tolerability of pharmacological treatment of alcohol
dependence: comprehensive review of evidence. Drug Saf.
2016;39(7):627-45. doi: 10.1007/s40264-016-0416-y.
10. Grover S, Basu D. The revival (or, rather, survival) of
disulfiram. Addiction. 2004;99(6):785. doi: 10.1111/j.1360-
0443.2004.00779.x.
11. Sharma P, Murthy P, Bharath MM. Disulfiram in a ‘traditional’
medicine sold to patients with alcohol dependence in India.
Addiction. 2011;106(10):1870-1. doi: 10.1111/j.1360-
0443.2011.03506.x.
12. Sarkar S. Surreptitious use of disulfiram. Indian J Med Ethics.
2013;10(1):71. doi: 10.20529/ijme.2013.023.
13. Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy
in the treatment of alcohol dependence: a meta-analysis. PLoS
One. 2014;9(2):e87366. doi: 10.1371/journal.pone.0087366.
14. Kalra G, De Sousa A, Shrivastava A. Disulfiram in the
management of alcohol dependence: a comprehensive
clinical review. Open J Psychiatry. 2014;4(1):43-52. doi: 10.4236/ojpsych.2014.41007.
15. Mann S, Joseph J, Malik YK, Devi R. Development and
validation of a treatment compliance assessment scale for
clients with mental illnesses. Journal of Mental Health and
Human Behaviour. 2023;28(1):42-7. doi: 10.4103/jmhhb.
jmhhb_19_22.
16. Breslin FC, Sobell LC, Sobell MB, Agrawal S. A comparison
of a brief and long version of the Situational Confidence
Questionnaire. Behav Res Ther. 2000;38(12):1211-20. doi:
10.1016/s0005-7967(99)00152-7.
17. Joseph J, Basu D. Adverse drug reactions to disulfiram
treatment with or without alcohol challenge in the Indian
setting: systematic review. Journal of Postgraduate Medicine,
Education and Research. 2018;53(1):21-30. doi: 10.5005/jpjournals-10028-1307.
18. de Sousa A, de Sousa A. An open randomized study
comparing disulfiram and acamprosate in the treatment of
alcohol dependence. Alcohol Alcohol. 2005;40(6):545-8.
doi: 10.1093/alcalc/agh187.
19. de Sousa AA, de Sousa J, Kapoor H. An open randomized
trial comparing disulfiram and topiramate in the treatment of
alcohol dependence. J Subst Abuse Treat. 2008;34(4):460-3.
doi: 10.1016/j.jsat.2007.05.012.
20. Mangot AG, Murthy VS, Jamale S. Pattern of prescription,
dispensation and administration of disulfiram among patients
with alcohol use disorder attending a general hospital
psychiatry unit in rural India. Asian J Psychiatr. 2017;28:170-
4. doi: 10.1016/j.ajp.2017.05.002.
21. Dutta R, Gnanasekaran S, Suchithra S, Srilalitha V, Sujitha
R, Sivaranjani SS, et al. A population-based study on
alcoholism among adult males in a rural area, Tamil Nadu,
India. J Clin Diagn Res. 2014;8(6):JC01-3. doi: 10.7860/
jcdr/2014/6308.4411.
22. Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines
R, et al. Pharmacotherapy for adults with alcohol use disorders
in outpatient settings: a systematic review and meta-analysis.
Jama 2014;311(18):1889-900. doi: 10.1001/jama.2014.3628.
23. Nair UR, Vidhukumar K, Prabhakaran A. Age at onset of
alcohol use and alcohol use disorder: time-trend study in
patients seeking de-addiction services in Kerala. Indian
J Psychol Med. 2016;38(4):315-9. doi: 10.4103/0253-
7176.185958.
24. Reddy MP, Babu RS, Pathak SM, Venkateshwarlu S. The
clinical and demographic profile of male patients with alcohol
dependence syndrome. Indian J Psychol Med. 2014;36(4):418-
21. doi: 10.4103/0253-7176.140735.
25. Mukhopadhyay S, Biswas P. Socio-demographic, clinical
correlates and predictors of adverse outcome in substance use
disorder (SUD) patients attending the de-addiction clinic of
a tertiary care hospital in Eastern India. Bengal J Psychiatry.
2016;21(1):1-12. doi: 10.51332/bjp.2016.v21.i1.28.
26. Kulkarni RK, Biradar MK. Socio demographic profile of
substance user in de-addiction centre. Indian J Forensic
Community Med. 2018;5(3):193-6. doi: 10.18231/2394-
6776.2018.0044.
27. Sathyanarayana Rao TS, Nambi S, Chandrashekhar H.
Marriage, mental health and Indian legislation. Forensic
Psychiatry: Clinical Practice Guidelines for Psychiatrists in
India. Indian Psychiatric Society; 2009. p. 113-28.
28. Vignesh BT, Singh AK, Mohan SK, Murthy S, Joshi A.
Association between socio-demographics and alcohol
dependence among individuals living in an Indian setting.
Glob J Health Sci. 2014;6(3):16-26. doi: 10.5539/gjhs.
v6n3p16.
29. Dewani K, Mutalik NR, Choudhari SB. Clinical and sociodemographic profile of patients with alcohol dependence
syndrome: a hospital-based study. Psychiatry and Mental
Health. 2017;1(2):61-5.
30. Brewer C, Streel E, Skinner M. Supervised disulfiram’s superior
effectiveness in alcoholism treatment: ethical, methodological,
and psychological aspects. Alcohol Alcohol. 2017;52(2):213-
9. doi: 10.1093/alcalc/agw093.
31. Krampe H, Ehrenreich H. Supervised disulfiram as adjunct
to psychotherapy in alcoholism treatment. Curr Pharm Des.
2010;16(19):2076-90. doi: 10.2174/138161210791516431.
32. Brewer C. Supervised disulfiram is more effective in alcoholism
than naltrexone or camprosate - or even psychotherapy: how
it works and why it matters. Adicciones. 2005;17(4):285-96.
33. Mangot AG. Ethical aspects of surreptitious use
of disulfiram. J Subst Use. 2017;22(3):244-5. doi:
10.1080/14659891.2016.1208775.
34. Prasad S, Murthy P, Subbakrishna DK, Gopinath PS. Treatment
setting and follow-up in alcohol dependence. Indian J
Psychiatry. 2000;42(4):387-92.
35. Sidana A, Rai S, Chavan BS. Alcohol dependence syndrome:
one year outcome study. Delhi Psychiatry Journal.
2007;10(1):53-7.
36. Palatty PL, Saldanha E. Status of disulfiram in present
day alcoholic deaddiction therapy. Indian J Psychiatry.
2011;53(1):25-9. doi: 10.4103/0019-5545.75557.
37. Ehrlich RI, Woolf DC, Kibel DA. Disulfiram reaction in an
artist exposed to solvents. Occup Med (Lond). 2012;62(1):64-
6. doi: 10.1093/occmed/kqr172.
38. Brubaker RG, Prue DM, Rychtarik RG. Determinants of
disulfiram acceptance among alcohol patients: a test of the
theory of reasoned action. Addict Behav. 1987;12(1):43-51.
doi: 10.1016/0306-4603(87)90007-4.
39. Lanz J, Biniaz-Harris N, Kuvaldina M, Jain S, Lewis K,
Fallon BA. Disulfiram: mechanisms, applications, and
challenges. Antibiotics (Basel). 2023;12(3):524. doi: 10.3390/
antibiotics12030524.
40. Mark TL, Kranzler HR, Song X, Bransberger P, Poole
VH, Crosse S. Physicians’ opinions about medications
to treat alcoholism. Addiction. 2003;98(5):617-26. doi:
10.1046/j.1360-0443.2003.00377.x.
41. Van Zyl PM. Doctors’ views of disulfiram and their response
to relapse in alcohol-dependent patients, Free State, 2009. Afr
J Prim Health Care Fam Med. 2016;8(1):e1-7. doi: 10.4102/
phcfm.v8i1.1053.
)